Home / Inspections / 1181504

FDA Inspection 1181504 — Metropolitan Reproductive Medicine, P.C.

Metropolitan Reproductive Medicine, P.C. — FEI 3006721953

The FDA completed an inspection of Metropolitan Reproductive Medicine, P.C. on October 13, 2022 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 13, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1094874 (NAI Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1000715 (NAI Fri Jan 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904067 (VAI Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 810165 (VAI Fri Dec 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources